Senti Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Senti Biosciences's estimated annual revenue is currently $18.6M per year.
- Senti Biosciences received $53.0M in venture funding in February 2018.
- Senti Biosciences's estimated revenue per employee is $155,000
- Senti Biosciences's total funding is $159.9M.
Employee Data
- Senti Biosciences has 120 Employees.
- Senti Biosciences grew their employee count by -2% last year.
Senti Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Head People - VP People Strategy & Culture | Reveal Email/Phone |
3 | SVP, Head Legal Affairs | Reveal Email/Phone |
4 | VP Manufacturing Operations / Site Head | Reveal Email/Phone |
5 | VP, Head Quality and Regulatory Affairs | Reveal Email/Phone |
6 | VP, Research & Development Operations | Reveal Email/Phone |
7 | Head Research & Development and Chief Medical Officer | Reveal Email/Phone |
8 | VP CMC / Tech Ops | Reveal Email/Phone |
9 | Director, Analytical Development | Reveal Email/Phone |
10 | Associate Director, QA Validation | Reveal Email/Phone |
Senti Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Senti Biosciences?
Senti Biosciences is a team of engineers, scientists, and entrepreneurs on a mission to leverage synthetic biology to treat the most pressing diseases. They have pioneered new technology platforms to design synthetic gene circuits for adaptive cell and gene therapies. Their recently completed Series A round of funding will be used to further the growth of their scalable therapeutic design platform and advance therapeutic candidates towards the clinic. They are proud to count NEA, 8VC, Amgen Ventures, Pear Ventures, Lux Capital, Menlo Ventures, Allen & Company, Nest.Bio, Omega Funds, Goodman Capital, and LifeForce Capital among their investors.
keywords:N/A
$159.9M
Total Funding
120
Number of Employees
$18.6M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Senti Biosciences News
SOUTH SAN FRANCISCO, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. ("Senti Bio"), a leading Gene Circuit company today...
... senior scientist, Cancer Immunotherapy, Senti Biosciences, discusses combining IL-21 and IL-15 cytokines in NK-cell thearpy.
Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences giant Bayer. The company’s technology uses new computational biological techniques to manufactu ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Senti Biosciences, the leading gene circuit company focused on outsmarting complex ...
Tim Lu, co-founder and CEO of Senti Biosciences — a Bay Area-based company focused on the next generation of gene and cell therapies ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.6M | 120 | 0% | $67.4M |
#2 | $4.2M | 122 | -22% | $52.7M |
#3 | $35.6M | 128 | 16% | $226.1M |
#4 | $35.1M | 130 | 7% | N/A |
#5 | $26.9M | 131 | 10% | N/A |
Senti Biosciences Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-02-28 | $53.0M | Undisclosed | New Enterprise Associates | Article |